| Not Yet Recruiting | Assessment of Non Vascular Risk Factors for Severity of Diabetic Foot Ulcers (DFUs) NCT07193992 | Assiut University | — |
| Not Yet Recruiting | Wound Dressing Patch with Kelulut Honey-Infused Alginate (Tri-Gnate Alginate) for Effective Wound Care Managem NCT06873646 | Mohd Khairul Zul Hasymi Firdaus | EARLY_Phase 1 |
| Active Not Recruiting | Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers NCT06189638 | Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | Phase 2 |
| Unknown | The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer NCT05850611 | Mashhad University of Medical Sciences | EARLY_Phase 1 |
| Completed | Topical Insulin Dressing on Management of Diabetic Foot Ulcers NCT07432581 | Cairo University | N/A |
| Recruiting | Registry HBOT in DFU NCT06693180 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers NCT05417425 | Omeza, LLC | Phase 1 |
| Completed | Effectiveness of Buerger Allen Exercise Among Type 2 Diabetes Mellitus Patients With Foot Ulcer NCT05747872 | Gazi University | N/A |
| Completed | A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream NCT04945161 | Oneness Biotech Co., Ltd. | N/A |
| Unknown | A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Non-Healing Diabetic Foot Ulcers NCT02312596 | PRP Concepts, LLC | N/A |
| Terminated | Topical Oxygen Therapy for Diabetic Wounds NCT02313428 | Indiana University | N/A |
| Unknown | The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healin NCT04315909 | Mashhad University of Medical Sciences | Phase 2 / Phase 3 |
| Active Not Recruiting | Wound Healing Endpoint and Recurrence NCT02577120 | Sashwati Roy | Phase 1 / Phase 2 |
| Terminated | A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer NCT02667327 | Xequel Bio, Inc. | Phase 3 |
| Unknown | Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer NCT02402374 | Regen Lab SA | N/A |
| Completed | Omnigen DFU Pilot Study NCT03483467 | University Hospitals of Derby and Burton NHS Foundation Trust | N/A |
| Unknown | Evaluation of ABSOLVE in Diabetic Foot Ulcers NCT03037970 | Lynch Biologics LLC | Phase 2 |
| Completed | Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers NCT02880592 | Organogenesis | N/A |
| Completed | Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers NCT02844660 | MiMedx Group, Inc. | N/A |
| Terminated | TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers NCT02936115 | Osiris Therapeutics | Phase 4 |
| Unknown | Maggot Debridement Therapy Versus Conventional Dressing Therapy to Treat Diabetic Foot Ulcers NCT02816749 | The First Affiliated Hospital of Dalian Medical University | Phase 4 |
| Unknown | Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Ski NCT02672280 | South China Research Center for Stem Cell and Regenerative Medicine | Phase 1 / Phase 2 |
| Completed | Vitamin D Treatment of Diabetic Patients With Foot Ulcers NCT03813927 | Zealand University Hospital | N/A |
| Terminated | Passive Training as a Treatment for Diabetic Foot Ulcers NCT02785198 | Herlev Hospital | N/A |
| Unknown | Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers NCT02691234 | Hadassah Medical Organization | Phase 1 / Phase 2 |
| Completed | Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K NCT02707406 | BioTissue Holdings, Inc | N/A |
| Completed | Evaluation of Woulgan in Diabetic Foot Ulcer NCT02631512 | Biotec Pharmacon ASA | Phase 4 |
| Completed | Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulce NCT02652754 | Xequel Bio, Inc. | Phase 1 |
| Completed | Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPW NCT02470806 | Smith & Nephew, Inc. | N/A |
| Completed | Negative Pressure Wound Therapy as a Drug Delivery System NCT02463487 | University of Texas Southwestern Medical Center | N/A |
| Completed | Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers NCT02789033 | University of Guadalajara | Phase 3 |
| Unknown | Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers NCT02506452 | Alliqua BioMedical, Inc | N/A |
| Completed | dHACM In the Treatment of Diabetic Foot Ulcers NCT02587104 | MiMedx Group, Inc. | N/A |
| Completed | dHACM Mesh In the Treatment of Diabetic Foot Ulcers NCT02589210 | MiMedx Group, Inc. | N/A |
| Unknown | Effectiveness of Aurix Therapy in Diabetic Foot Ulcers NCT02352480 | Nuo Therapeutics | N/A |
| Withdrawn | Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) P NCT02367690 | Karyopharm Therapeutics Inc | Phase 1 / Phase 2 |
| Completed | UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repos NCT02463500 | University of Texas Southwestern Medical Center | — |
| Completed | Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers NCT02389010 | Centro Nazionale Sangue | Phase 3 |
| Completed | Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers NCT02331147 | Musculoskeletal Transplant Foundation | N/A |
| Unknown | A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers NCT02081352 | TRx Wound Care Limited | Phase 4 |
| Unknown | A Comparison of TCC-EZ Using Human Amnion Allograft vs TCC-EZ and Standard Wound Care in Treating Diabetic Foo NCT02344329 | University of North Dakota | Phase 4 |
| Completed | Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance an NCT02091778 | Molnlycke Health Care AB | N/A |
| Completed | Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers NCT02209051 | Integra LifeSciences Corporation | N/A |
| Terminated | Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds NCT02071979 | Arteriocyte, Inc. | N/A |
| Completed | Santyl Applications to Diabetic Foot Ulcers NCT02111291 | Healthpoint | Phase 4 |
| Completed | TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evalua NCT01964521 | Molnlycke Health Care AB | N/A |
| Terminated | Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabet NCT02036528 | Royer Biomedical, Inc. | Phase 1 / Phase 2 |
| Completed | Effect of Topic Pirfenidone in Diabetic Ulcers NCT02222376 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 3 |
| Terminated | Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers NCT01816633 | Cytomedix | N/A |
| Unknown | WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU NCT01537016 | Systagenix Wound Management | N/A |
| Terminated | Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diab NCT01849965 | Integra LifeSciences Corporation | Phase 3 |
| Completed | Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers NCT02222506 | KLOX Technologies Inc. | N/A |
| Withdrawn | WEMR With Clinical Decision Support for Diabetic Foot Ulcers NCT02055755 | Winthrop University Hospital | — |
| Unknown | A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Ca NCT01824407 | SANUWAVE, Inc. | Phase 3 |
| Terminated | Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers NCT01830348 | Integra LifeSciences Corporation | Phase 3 |
| Unknown | Safety Study of Topical Human FGF-1 for Wound Healing NCT00916292 | Phage Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers NCT01070433 | Skingenix, Inc. | Phase 2 |
| Unknown | Evaluation of a 'Hand-held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring ( NCT01651845 | University Health Network, Toronto | — |
| Completed | A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a D NCT01490879 | OcuNexus Therapeutics, Inc. | Phase 2 |
| Completed | Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ul NCT01596920 | Osiris Therapeutics | Phase 4 |
| Completed | Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers NCT02134132 | Royan Institute | Phase 1 / Phase 2 |
| Completed | Using Santyl on Diabetic Foot Ulcers NCT01408277 | Healthpoint | Phase 4 |
| Completed | Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon NCT01382628 | Georgetown University | — |
| Completed | Wound Edge Changes Following Treatment With Santyl NCT01197898 | Healthpoint | Phase 4 |
| Completed | A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pil NCT01154374 | Skingenix, Inc. | Phase 2 |
| Completed | Instant Total Contact Cast to Heal Diabetic Foot Ulcers NCT01221207 | University of Texas Southwestern Medical Center | N/A |
| Completed | LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers NCT01454401 | Reapplix | N/A |
| Completed | Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers NCT01143727 | Healthpoint | Phase 4 |
| Completed | Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulc NCT01098357 | Virchow Group | Phase 1 / Phase 2 |
| Completed | A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers NCT01143714 | Healthpoint | Phase 4 |
| Withdrawn | Developing a Diabetic Foot Ulcer Protocol NCT01068171 | The University of Texas Health Science Center, Houston | N/A |
| Unknown | Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers NCT01137903 | Universidad Complutense de Madrid | N/A |
| Completed | Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers NCT01353495 | Stryker Trauma and Extremities | N/A |
| Withdrawn | Clinical Evaluation of the SNaP Wound Care System NCT01113658 | 3M | N/A |
| Completed | Santyl vs. Sharp Debridement of Diabetic Foot Wounds NCT01056198 | Healthpoint | Phase 4 |
| Completed | Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers NCT01291160 | Neogenix, LLC dba Ogenix | Phase 2 / Phase 3 |
| Withdrawn | Clinical and Cost Effectiveness of Different Dressing Materials in Diabetic Foot Ulcers NCT01105884 | M.V. Hospital for Diabetes | N/A |
| Completed | Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness NCT00971048 | Healthpoint | N/A |
| Completed | Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative P NCT00847730 | KCI USA, Inc | N/A |
| Completed | Study of Maggot Therapy in Diabetic Foot Ulcers NCT01681160 | Kerman Medical University | N/A |
| Terminated | The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer NCT00958711 | Baxter Healthcare Corporation | N/A |
| Terminated | The AutoloGel™ Post-Market Surveillance (TAPS) Program NCT00762138 | Cytomedix | N/A |
| Unknown | Monochromatic Phototherapy on Diabetic Foot Ulcers NCT00859599 | Biolight AB | Phase 3 |
| Completed | Evaluation of the Effect of Vivostat Platelet Rich Fibrin(PRF) in the Treatment of Diabetic Foot Ulcers NCT00770939 | Vivostat | Phase 4 |
| Terminated | A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers NCT00761176 | Regenesis Biomedical, Inc. | N/A |
| Completed | Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Fo NCT00536744 | SANUWAVE, Inc. | Phase 3 |
| Completed | Non-Invasive Assessment of Wound Healing With Optical Methods NCT00578604 | Drexel University College of Medicine | — |
| Terminated | A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies NCT00605189 | KCI USA, Inc | N/A |
| Unknown | Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers NCT00446472 | Southern California Institute for Research and Education | N/A |
| Terminated | Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers NCT00316537 | CoMentis | Phase 1 / Phase 2 |
| Completed | Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers NCT00617916 | HyperMed | — |
| Unknown | Negative Pressure Wound Therapy Registry NCT02467998 | U.S. Wound Registry | — |
| Unknown | Cellular and Tissue Based Therapy Registry NCT02322554 | U.S. Wound Registry | — |
| Completed | Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation NCT00463671 | Assaf-Harofeh Medical Center | N/A |
| Completed | Gene Therapy to Improve Wound Healing in Patients With Diabetes NCT00065663 | Tissue Repair Company | Phase 1 |
| Completed | Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers NCT00432965 | KCI USA, Inc | N/A |
| Completed | Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3 NCT00013299 | US Department of Veterans Affairs | Phase 2 |
| Completed | Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing NCT00011531 | US Department of Veterans Affairs | Phase 2 |
| Completed | A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk NCT00013286 | US Department of Veterans Affairs | — |
| Completed | MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers NCT00563433 | Abeona Therapeutics, Inc | Phase 3 |
| Completed | MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers NCT00563394 | Abeona Therapeutics, Inc | Phase 3 |
| Unknown | Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot Ulcers NCT00475202 | Assaf-Harofeh Medical Center | — |
| Withdrawn | A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treat NCT02120755 | Liventa Bioscience | Phase 4 |